Company Directory - Merck Canada
Company Details - Merck Canada
Merck Canada
Merck Canada is a leading pharmaceutical company focused on the development and production of medicines, vaccines, and health solutions for a variety of medical needs.
CCI Score
CCI Score: Merck Canada
3.65
-5.41%
Latest Event
Merck Canada Reduces Sponsorship for Pride Toronto
Merck Canada announced it will reduce its sponsorship contribution to Pride Toronto's annual 2SLGBTQ+ festival, a decision that could significantly impact the festival's capacity to deliver on its commitments to the community. Discussions regarding the sponsorship are still ongoing.
Take Action
So what can you do? Support by shopping, spreading the word, or offering your support.
- Shop Alternatives
SEE ALL - Use Your Voice
OTHER TOOLS - Investigate
- Share the Score
SUPPORT CCI
OBJECTOR
Merck Canada is currently rated as an Objector.
Latest Events
- JUN012025
Merck Canada announced it will reduce its sponsorship contribution to Pride Toronto's annual 2SLGBTQ+ festival, a decision that could significantly impact the festival's capacity to deliver on its commitments to the community. Discussions regarding the sponsorship are still ongoing.
- MAY142025
The OpenSecrets profile reveals that Merck & Co, associated with Merck Canada, spent $10,180,000 on lobbying during the 2023 cycle. The data, sourced from Senate Office of Public Records and downloaded on May 14, 2025, highlights the company's significant investment in political influence.
-40
Political Contributions and Lobbying Efforts
May 31
The disclosed lobbying expenditure of over $10 million indicates a strong focus on deploying corporate resources to influence political processes. Such extensive lobbying efforts can undermine democratic accountability and facilitate corporate interests at the expense of public welfare, aligning with concerns of corporate complicity in fostering environments where authoritarian practices may thrive.
- FEB062025
The OpenSecrets profile reports that Merck & Co (related to Merck Canada) spent $2,404,248 in campaign contributions and $9,320,000 on lobbying in the 2024 cycle, indicating significant corporate political activity aimed at influencing policy outcomes.
-50
Political Contributions and Lobbying Efforts
May 31
The reported high levels of campaign contributions and lobbying expenditures indicate substantial corporate involvement in political processes. Such activities can enable meritorious influence over policymaking, potentially undercutting democratic accountability and favoring corporate interests, which in a left-leaning, anti-fascist view aligns with authoritarian economic practices.
- APR112024
The 2023 Sustainability Report outlines Merck's commitment to human rights by detailing comprehensive due diligence processes, supplier risk assessments, extensive training on social and labor standards, and a robust whistleblowing system. These actions are aimed at preventing human rights violations and ensuring ethical practices throughout its operations and supply chain.
+80
Labor Relations and Human Rights Practices
May 31
The report demonstrates strong adherence to human rights protocols with detailed due diligence, risk assessments at sites and across the supply chain, and mandatory training for management on upholding labor and human rights standards. These measures strengthen worker rights and support marginalized groups, aligning with anti-authoritarian and progressive policies.
+70
Supply Chain Ethics
May 31
The sustainability report details thorough integration of human rights due diligence into the supply chain, including risk assessments and supplier monitoring, ensuring that ethical sourcing practices are maintained. This is vital to uphold supplier responsibility and mitigate the risk of human rights violations.
- MAR072024
Merck Canada's 2023 Annual Report details comprehensive measures to ensure a responsible supply chain, including robust supplier risk assessments, due diligence on conflict minerals, strict enforcement of labor and human rights standards, and ongoing sustainability initiatives.
+60
Supply Chain Ethics
May 31
The report outlines detailed supply chain strategies including supplier risk assessments, conflict minerals due diligence, and traceability measures, indicating a strong commitment to ethical sourcing. These measures contribute positively to supply chain ethics by ensuring adherence to human rights and environmental standards.
+50
Labor Relations and Human Rights Practices
May 31
The report emphasizes adherence to international labor standards and human rights, detailing measures such as regular audits, prohibition of child labor, and ensuring a living wage for workers. These practices support fair labor relations and enhance the company’s ethical responsibility.
- FEB082024
On February 8, 2024, Merck Canada announced a multi-year collaboration with the Vector Institute, a leading AI research organization, to drive innovation in healthcare. The partnership aims to leverage advanced AI research and a robust ecosystem of experts to explore new solutions to healthcare challenges in Canada and beyond.
+50
Technology and Services Impact
May 31
This collaboration highlights Merck Canada's commitment to leveraging advanced AI technologies to improve healthcare outcomes. By partnering with the Vector Institute, Merck Canada is investing in innovative technological research that can drive public benefit and improved patient care, aligning with progressive, anti-authoritarian values.
- JUN012023
Merck has filed a lawsuit arguing that the Medicare drug price negotiation aspect of the Inflation Reduction Act amounts to extortion and violates the U.S. Constitution, while also spending $8.2 million on federal lobbying. This move reflects the company's vigorous opposition to regulatory measures aimed at lowering drug prices.
-80
Political Contributions and Lobbying Efforts
May 31
The firm's legal challenge and significant lobbying expenditure signal a concerted effort to oppose progressive drug pricing reforms intended to make medications more affordable. This alignment with interests that resist public policy initiatives aimed at reducing healthcare costs raises concerns from an anti-fascist, pro-worker perspective.
Merck is fighting Inflation Reduction Act in court, lobbying - Inquirer.com
- APR012023
Merck Canada outlines its philanthropic initiative, providing charitable contributions, donations, and grants to support health care, science education, and various community-based charitable initiatives. The program is geared exclusively towards legally registered non-profit organizations in Canada, thereby reinforcing its commitment to community well-being and ethical business practices.
+75
Business Practices and Ethical Responsibility
May 31
Merck Canada's initiative to provide philanthropic funding reflects a commitment to ethical business practices and community support. By directing funds to healthcare, educational, and community initiatives, the company is actively contributing to the welfare of marginalized groups and reinforcing values that counter authoritarian economic practices.
- JAN012023
Merck Canada is actively engaging in lobbying as evidenced by its 12-month summary report with the Office of the Commissioner of Lobbying of Canada. The company is seeking to influence legislative reforms and trade negotiations (including TRIPs, CETA, and TPP) to enhance intellectual property protection, which may prioritize corporate interests over public health needs.
-40
Political Contributions and Lobbying Efforts
May 31
The lobbying efforts undertaken by Merck Canada to secure stronger intellectual property legislation and favorable trade conditions demonstrate a self-serving initiative that prioritizes corporate profit over public access to medicines and equitable health policies. This behavior reflects problematic corporate political influence which can undermine democratic processes and public interest, thus earning a negative score.
Merck Canada Inc. / Marwan Akar, PRESIDENT - 12-Month Lobbying Summary
- JUN012021
Merck Canada, through its global transparency disclosures page, reveals its costs associated with lobbying in the EU and U.S., along with detailed information on scientific grants, payments to healthcare professionals, and post-marketing requirements. This move demonstrates the company’s commitment to transparency in its political and advocacy activities.
+70
Political Contributions and Lobbying Efforts
May 31
By publicly disclosing its lobbying expenditures and advocacy costs, Merck Canada enhances transparency regarding its political engagements. This openness supports accountability and counters the opaque practices that can enable authoritarian influences, aligning with anti-fascist and progressive values.
Alternatives
Brentford, United Kingdom
17.84
Mumbai, India
-2.38
New York, United States
30.00
Darmstadt, Germany
12.15
_0.png?VersionId=E54j6B2ssY0mos4wxJcXCOh7Hall1IAR)
New York, United States
-1.58
Tokyo, Japan
-7.34
North Chicago, United States
-31.13
Hyderabad, India
-52.48
Corporation
27.72
Corporation
-4.72
Industries
- 325412
- Pharmaceutical Preparation Manufacturing
- 325414
- Biological Product (except Diagnostic) Manufacturing
- 424210
- Drugs and Druggists' Sundries Merchant Wholesalers